{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T17:38:26Z","timestamp":1787420306592,"version":"build-2736575974"},"reference-count":53,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/gjcx1238","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:58:29Z","timestamp":1740707909000},"page":"705-722","source":"Crossref","is-referenced-by-count":3,"title":["Sociodemographic characteristics associated with pancreatic cancer incidence and mortality among Blacks in the United States: a SEER-based study"],"prefix":"10.62347","volume":"15","author":[{"given":"Esther","family":"Frimpong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3322\/caac.21626","article-title":"Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma","volume":"70","author":"Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD and Thomas CR Jr. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin 2020; 70: 375-403.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN and Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024; 74: 12-49.","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","article-title":"Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution","volume":"20","author":"Li","year":"2022","unstructured":"Li Q, Feng Z, Miao R, Liu X, Liu C and Liu Z. Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution. World J Surg Oncol 2022; 20: 11.","journal-title":"World J Surg Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1053\/j.gastro.2020.10.007","article-title":"Worldwide burden of, risk factors for, and trends in pancreatic cancer","volume":"160","author":"Huang","year":"2021","unstructured":"Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, Ng K, Chong C, Zheng ZJ and Wong MCS. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology 2021; 160: 744-754.","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"10732748231154711","DOI":"10.1177\/10732748231154711","article-title":"Early diagnosis of pancreatic cancer: clinical premonitions, timely precursor detection and increased curative-intent surgery","volume":"30","author":"S&#xF8","year":"2023","unstructured":"S&#xF8;reide K, Ismail W, Roals&#xF8; M, Ghotbi J and Zaharia C. Early diagnosis of pancreatic cancer: clinical premonitions, timely precursor detection and increased curative-intent surgery. Cancer Control 2023; 30: 10732748231154711.","journal-title":"Cancer Control"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pan.2017.11.008","article-title":"Impact of age on survival of patients with pancreatic cancer after surgery: analysis of SEER data","volume":"18","author":"Li","year":"2018","unstructured":"Li X, Liu Z, Ye Z, Gou S and Wang C. Impact of age on survival of patients with pancreatic cancer after surgery: analysis of SEER data. Pancreatology 2018; 18: 133-138.","journal-title":"Pancreatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.suc.2016.07.008","article-title":"Definition and management of borderline resectable pancreatic cancer","volume":"96","author":"Denbo","year":"2016","unstructured":"Denbo JW and Fleming JB. Definition and management of borderline resectable pancreatic cancer. Surg Clin North Am 2016; 96: 1337-1350.","journal-title":"Surg Clin North Am"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1038\/s41598-020-61487-0","article-title":"Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review","volume":"10","author":"Liu","year":"2020","unstructured":"Liu Q, Zhang R, Michalski CW, Liu B, Liao Q and Kleeff J. Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review. Sci Rep 2020; 10: 4444.","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ije\/dyx232","article-title":"Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data","volume":"47","author":"Gordon-Dseagu","year":"2018","unstructured":"Gordon-Dseagu VL, Devesa SS, Goggins M and Stolzenberg-Solomon R. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol 2018; 47: 427-439.","journal-title":"Int J Epidemiol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Tavakkoli A, Singal AG, Waljee AK, Elmunzer BJ, Pruitt SL, McKey T, Rubenstein JH, Scheiman JM and Murphy CC. Racial disparities and trends in pancreatic cancer incidence and mortality in the United States. Clin Gastroenterol Hepatol 2020; 18: 171-178, e110.","DOI":"10.1016\/j.cgh.2019.05.059"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","unstructured":"McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG and McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018; 24: 4846-4861.","journal-title":"World J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MPA.0000000000000323","article-title":"Pancreatic cancer disparities in African Americans","volume":"44","author":"Khawja","year":"2015","unstructured":"Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE and Van Buren G 2nd. Pancreatic cancer disparities in African Americans. Pancreas 2015; 44: 522-527.","journal-title":"Pancreas"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jnma.2023.01.008","article-title":"Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans","volume":"115","author":"Telisnor","year":"2023","unstructured":"Telisnor G, DeRemer DL, Frimpong E, Agyare E, Allen J, Ricks-Santi L, Han B, George T and Rogers SC. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. J Natl Med Assoc 2023; 115: 164-174.","journal-title":"J Natl Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Herremans KM, Riner AN, Winn RA and Trevino JG. Diversity and inclusion in pancreatic cancer clinical trials. Gastroenterology 2021; 161: 1741-1746, e1743.","DOI":"10.1053\/j.gastro.2021.06.079"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1200\/JCO.21.02492","article-title":"Eligibility criteria perpetuate disparities in enrollment and participation of black patients in pancreatic cancer clinical trials","volume":"40","author":"Riner","year":"2022","unstructured":"Riner AN, Girma S, Vudatha V, Mukhopadhyay N, Skoro N, Gal TS, Freudenberger DC, Herremans KM, George TJ and Trevino JG. Eligibility criteria perpetuate disparities in enrollment and participation of black patients in pancreatic cancer clinical trials. J Clin Oncol 2022; 40: 2193-2202.","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Smith JK, Ng SC, Zhou Z, Carroll JE, McDade TP, Shah SA and Tseng JF. Does increasing insurance improve outcomes for US cancer patients? J Surg Res 2013; 185: 15-20.","DOI":"10.1016\/j.jss.2013.05.058"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/SLA.0b013e3180691579","article-title":"National failure to operate on early stage pancreatic cancer","volume":"246","author":"Bilimoria","year":"2007","unstructured":"Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP and Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg 2007; 246: 173-180.","journal-title":"Ann Surg"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/cncr.24836","article-title":"Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process","volume":"116","author":"Riall","year":"2010","unstructured":"Riall TS, Townsend CM Jr, Kuo YF, Freeman JL and Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer 2010; 116: 930-939.","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamasurg.2015.4239","article-title":"Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer","volume":"151","author":"Shapiro","year":"2016","unstructured":"Shapiro M, Chen Q, Huang Q, Boosalis VA, Yoon CH, Saund MS, Whang EE and Gold JS. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg 2016; 151: 338-345.","journal-title":"JAMA Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00432-012-1156-8","article-title":"Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis","volume":"138","author":"Singal","year":"2012","unstructured":"Singal V, Singal AK and Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol 2012; 138: 715-722.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Amirian H, Kwon D, Vickers SM, Livingstone A, Jayaweera D and Saluja AK; Pancreas Research Group. Racial disparity between Whites and African Americans in incidence and outcome of pancreatic cancer: have we made a difference? Gastroenterology 2022; 162: 1346-1348, e1343.","DOI":"10.1053\/j.gastro.2021.12.256"},{"key":"ref21","unstructured":"Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 22 Registries (excl IL and MA), Nov 2022 Sub (2000-2020) - Linked To County Attributes - Time Dependent (1990-2021) Income\/Rurality, 1969-2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission. In."},{"key":"ref22","unstructured":"Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Plus Limited-Field Data, 22 Registries, Nov 2022 Sub (2000-2020) - Linked To County Attributes - Total U.S., 1969-2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"key":"ref23","unstructured":"Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2022) &#x003C;Katrina\/Rita Population Adjustment&#x003E;, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2024. Underlying mortality data provided by NCHS (www.cdc.gov\/nchs)."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-08167-5","article-title":"Automated real-world data integration improves cancer outcome prediction","volume":"636","author":"Jee","year":"2024","unstructured":"Jee J, Fong C, Pichotta K, Tran TN, Luthra A, Waters M, Fu C, Altoe M, Liu SY, Maron SB, Ahmed M, Kim S, Pirun M, Chatila WK, de Bruijn I, Pasha A, Kundra R, Gross B, Mastrogiacomo B, Aprati TJ, Liu D, Gao J, Capelletti M, Pekala K, Loudon L, Perry M, Bandlamudi C, Donoghue M, Satravada BA, Martin A, Shen R, Chen Y, Brannon AR, Chang J, Braunstein L, Li A, Safonov A, Stonestrom A, Sanchez-Vela P, Wilhelm C, Robson M, Scher H, Ladanyi M, Reis-Filho JS, Solit DB, Jones DR, Gomez D, Yu H, Chakravarty D, Yaeger R, Abida W, Park W, O&#x2019;Reilly EM, Garcia-Aguilar J, Socci N, Sanchez-Vega F, Carrot-Zhang J, Stetson PD, Levine R, Rudin CM, Berger MF, Shah SP, Schrag D, Razavi P, Kehl KL, Li BT, Riely GJ and Schultz N; MSK Cancer Data Science Initiative Group. Automated real-world data integration improves cancer outcome prediction. Nature 2024; 636: 728-736.","journal-title":"Nature"},{"key":"ref25","unstructured":"Surveillance Research Program, National Cancer Institute SEER*Stat software (seer.cancer.gov\/seerstat) version &#x003C;8.4.3&#x003E;."},{"key":"ref26","unstructured":"Joinpoint Regression Program. 5.0.2 edition. Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute; 2023."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ and Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.","journal-title":"Stat Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0974-7788.76794","article-title":"Understanding survival analysis: Kaplan-Meier estimate","volume":"1","author":"MK","year":"2010","unstructured":"Goel MK, Khanna P and Kishore J. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res 2010; 1: 274-278.","journal-title":"Int J Ayurveda Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C and Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404.","journal-title":"Cancer Discov"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C and Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: pl1.","DOI":"10.1126\/scisignal.2004088"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"Bruijn I","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, Abeshouse A, Baiceanu D, Ciftci E, Dogrusoz U, Dufilie A, Erkoc Z, Garcia Lara E, Fu Z, Gross B, Haynes C, Heath A, Higgins D, Jagannathan P, Kalletla K, Kumari P, Lindsay J, Lisman A, Leenknegt B, Lukasse P, Madela D, Madupuri R, van Nierop P, Plantalech O, Quach J, Resnick AC, Rodenburg SYA, Satravada BA, Schaeffer F, Sheridan R, Singh J, Sirohi R, Sumer SO, van Hagen S, Wang A, Wilson M, Zhang H, Zhu K, Rusk N, Brown S, Lavery JA, Panageas KS, Rudolph JE, LeNoue-Newton ML, Warner JL, Guo X, Hunter-Zinck H, Yu TV, Pilai S, Nichols C, Gardos SM, Philip J; AACR Project GENIE BPC Core Team, AACR Project GENIE Consortium, Kehl KL, Riely GJ, Schrag D, Lee J, Fiandalo MV, Sweeney SM, Pugh TJ, Sander C, Cerami E, Gao J and Schultz N. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Cancer Res 2023; 83: 3861-3867.","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1089\/heq.2019.0057","article-title":"Disparities in pancreatic cancer treatment and outcomes","volume":"3","author":"Noel","year":"2019","unstructured":"Noel M and Fiscella K. Disparities in pancreatic cancer treatment and outcomes. Health Equity 2019; 3: 532-540.","journal-title":"Health Equity"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cac2.12375","article-title":"Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study","volume":"43","author":"Niksic","year":"2023","unstructured":"Niksic M, Minicozzi P, Weir HK, Zimmerman H, Schymura MJ, Rees JR, Coleman MP and Allemani C; US CONCORD Working Group. Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study. Cancer Commun (Lond) 2023; 43: 87-99.","journal-title":"Cancer Commun (Lond)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1245\/s10434-021-10868-4","article-title":"Access denied: inequities in clinical trial enrollment for pancreatic cancer","volume":"29","author":"Eskander","year":"2022","unstructured":"Eskander MF, Gil L, Beal EW, Li Y, Hamad A, Oppong B, Obeng-Gyasi S and Tsung A. Access denied: inequities in clinical trial enrollment for pancreatic cancer. Ann Surg Oncol 2022; 29: 1271-1277.","journal-title":"Ann Surg Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"PS","year":"2014","unstructured":"Rosenberg PS, Check DP and Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 2014; 23: 2296-2302.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.12688\/f1000research.54390.1","article-title":"Pancreatic cancer incidence trends in the United States from 2000-2017: analysis of surveillance, epidemiology and end results (SEER) database","volume":"10","author":"Ali","year":"2021","unstructured":"Ali H, Pamarthy R, Vallabhaneni M, Sarfraz S, Ali H and Rafique H. Pancreatic cancer incidence trends in the United States from 2000-2017: analysis of surveillance, epidemiology and end results (SEER) database. F1000Res 2021; 10: 529.","journal-title":"F1000Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/oncolo\/oyad080","article-title":"Management of patients with pancreatic cancer using the &#x201C;right track&#x201D; model","volume":"28","author":"Rosenzweig","year":"2023","unstructured":"Rosenzweig A, Berlin J, Chari S, Kindler H, Matrisian L, Mayoral A, Mills J, Nissen N, Picozzi V, Zelada-Arenas F and Fleming J. Management of patients with pancreatic cancer using the &#x201C;right track&#x201D; model. Oncologist 2023; 28: 584-595.","journal-title":"Oncologist"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1533033820962117","DOI":"10.1177\/1533033820962117","article-title":"Pancreatic cancer: a review of risk factors, diagnosis, and treatment","volume":"19","author":"Zhao","year":"2020","unstructured":"Zhao Z and Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat 2020; 19: 1533033820962117.","journal-title":"Technol Cancer Res Treat"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/cancers15030870","article-title":"Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018","volume":"15","author":"Samaan","year":"2023","unstructured":"Samaan JS, Abboud Y, Oh J, Jiang Y, Watson R, Park K, Liu Q, Atkins K, Hendifar A, Gong J, Osipov A, Li D, Nissen NN, Pandol SJ, Lo SK and Gaddam S. Pancreatic cancer incidence trends by race, ethnicity, age and sex in the United States: a population-based study, 2000-2018. Cancers (Basel) 2023; 15: 870.","journal-title":"Cancers (Basel)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.7314\/APJCP.2015.16.14.5619","article-title":"Pancreatic cancer: pathogenesis and diagnosis","volume":"16","author":"Goral","year":"2015","unstructured":"Goral V. Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J Cancer Prev 2015; 16: 5619-5624.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.55320\/mjz.44.4.96","article-title":"Pancreatic cancer: patterns in a low- to middle-income population, Zambia","volume":"44","author":"Asombang","year":"2017","unstructured":"Asombang A, Madsen R, Simuyandi M, Phiri G, Bechtold M, Ibdah J, Lishimpi K and Banda L. Pancreatic cancer: patterns in a low- to middle-income population, Zambia. Med J Zambia 2017; 44: 212-217.","journal-title":"Med J Zambia"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"633","DOI":"10.21037\/jgo-20-39","article-title":"Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients","volume":"11","author":"Madnick","year":"2020","unstructured":"Madnick D, Handorf E, Ortiz A, Sorice K, Nagappan L, Moccia M, Cheema K, Vijayvergia N, Dotan E and Lynch SM. Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients. J Gastrointest Oncol 2020; 11: 633-643.","journal-title":"J Gastrointest Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1245\/s10434-021-11258-6","article-title":"Disparities in access to oncologic care in pancreatic cancer: a systematic review","volume":"29","author":"Fonseca","year":"2022","unstructured":"Fonseca AL, Khan H, Mehari KR, Cherla D, Heslin MJ and Johnston FM. Disparities in access to oncologic care in pancreatic cancer: a systematic review. Ann Surg Oncol 2022; 29: 3232-3250.","journal-title":"Ann Surg Oncol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"487","DOI":"10.21037\/jgo.2016.03.03","article-title":"Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises","volume":"7","author":"Mei","year":"2016","unstructured":"Mei L, Du W and Ma WW. Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises. J Gastrointest Oncol 2016; 7: 487-494.","journal-title":"J Gastrointest Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1245\/s10434-024-15352-3","article-title":"Minorities face delays to pancreatic cancer treatment regardless of diagnosis setting","volume":"31","author":"Fallon","year":"2024","unstructured":"Fallon J, Standring O, Vithlani N, Demyan L, Shah M, Gazzara E, Hartman S, Pasha S, King DA, Herman JM, Weiss MJ, DePeralta D and Deutsch G. Minorities face delays to pancreatic cancer treatment regardless of diagnosis setting. Ann Surg Oncol 2024; 31: 4986-4996.","journal-title":"Ann Surg Oncol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1245\/s10434-022-12741-4","article-title":"Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the central pancreatic consortium","volume":"30","author":"Ogobuiro","year":"2023","unstructured":"Ogobuiro I, Collier AL, Khan K, de Castro Silva I, Kwon D, Wilson GC, Schwartz PB, Parikh AA, Hammill C, Kim HJ, Kooby DA, Abbott D, Maithel SK, Snyder RA, Ahmad SA, Merchant NB and Datta J. Racial disparity in pathologic response following neoadjuvant chemotherapy in resected pancreatic cancer: a multi-institutional analysis from the central pancreatic consortium. Ann Surg Oncol 2023; 30: 1485-1494.","journal-title":"Ann Surg Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"102408","DOI":"10.1016\/j.canep.2023.102408","article-title":"Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets","volume":"86","author":"Wells","year":"2023","unstructured":"Wells M, Rutherford MJ and Lambert PC. Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets. Cancer Epidemiol 2023; 86: 102408.","journal-title":"Cancer Epidemiol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"MB","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC, Karlan BY, Khan S, Klein C, Kohlmann W; CGC, Kurian AW, Laronga C, Litton JK, Mak JS; LCGC, Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC, Senter-Jamieson L; CGC, Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD and Dwyer MA. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2021; 19: 77-102.","journal-title":"J Natl Compr Canc Netw"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"847760","DOI":"10.3389\/fendo.2022.847760","article-title":"Identification of the shared gene signatures and biological mechanism in type 2 diabetes and pancreatic cancer","volume":"13","author":"Hu","year":"2022","unstructured":"Hu Y, Zeng N, Ge Y, Wang D, Qin X, Zhang W, Jiang F and Liu Y. Identification of the shared gene signatures and biological mechanism in type 2 diabetes and pancreatic cancer. Front Endocrinol (Lausanne) 2022; 13: 847760.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Cowan RW, Pratt ED, Kang JM, Zhao J, Wilhelm JJ, Abdulla M, Qiao EM, Brennan LP, Ulintz PJ, Bellin MD and Rhim AD. Pancreatic cancer-related mutational burden is not increased in a patient cohort with clinically severe chronic pancreatitis. Clin Transl Gastroenterol 2021; 12: e00431.","DOI":"10.14309\/ctg.0000000000000431"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1111\/cas.16302","article-title":"Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis","volume":"115","author":"Toyoda","year":"2024","unstructured":"Toyoda T, Miura N, Kato S, Masuda T, Ohashi R, Matsushita A, Matsuda F, Ohtsuki S, Katakura A and Honda K. Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis. Cancer Sci 2024; 115: 3622-3635.","journal-title":"Cancer Sci"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10552-022-01637-z","article-title":"Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study","volume":"34","author":"Gram","year":"2023","unstructured":"Gram IT, Park SY, Wilkens LR, Le Marchand L and Setiawan VW. Smoking and pancreatic cancer: a sex-specific analysis in the Multiethnic Cohort study. Cancer Causes Control 2023; 34: 89-100.","journal-title":"Cancer Causes Control"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/2\/ajcr0161677.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:24Z","timestamp":1766023164000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/15\/2\/ajcr0161677.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/gjcx1238","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}